126 results
Page 5 of 7
6-K
EX-99.1
yqre5rvvqzsj1u3oy
31 Oct 13
Teva Reports Third Quarter 2013 Results
12:00am
6-K
rntmrpkvt uzymjczio
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
4ju lk49x
30 Oct 13
Teva Announces Departure of President and Ceo
12:00am
6-K
EX-99.1
h6pafy1y
10 Oct 13
Live Filing
12:00am
6-K
EX-99.1
b2fouyfxeatb
9 Oct 13
Teva R&D in Focus - Respiratory Webinar for the investment communityOctober 8th, 2013
12:00am
6-K
EX-99.1
ls5bzorj0 8vd4ima
4 Oct 13
Live Filing
12:00am
6-K
EX-99.1
3ktyyaacrz
3 Oct 13
Teva Announces Favorable Ruling on Copaxone Patent Litigation In the Netherlands
12:00am
6-K
EX-99.1
4v68y6i
3 Oct 13
Teva to Present Further Results of Twenty-year Open-label Extension Study of Glatiramer Acetate 20 MG Daily for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
uf9f hpv9ghbn
1 Oct 13
Teva Announces Launch of Generic Zemplar® In the United States
12:00am
6-K
EX-99.1
okl1qx
1 Oct 13
Live Filing
12:00am
6-K
EX-99.1
j795caq2 cbts
30 Sep 13
Live Filing
12:00am
6-K
EX-99.1
poojtq1ee108d
26 Sep 13
Live Filing
12:00am
6-K
EX-99.1
x9vyu
24 Sep 13
Teva Announces Exclusive Launch of Generic Adenoscan® In the United States
12:00am
6-K
EX-99.1
nfylo3n
23 Sep 13
Teva Announces Favorable Court Ruling In Azilect® Patent Infringement Litigation Against Mylan
12:00am
6-K
EX-99.1
dsky2v5
20 Sep 13
Teva Announces Exclusive Launch of Generic Niaspan® In the United States
12:00am
6-K
EX-99.1
di2eimfg355an5q46wn
17 Sep 13
Fda Approves Teva’s Treanda® (Bendamustine Hci) Injection, a New Liquid Formulation
12:00am
6-K
EX-99.1
uz377kkj
30 Aug 13
Live Filing
12:00am
6-K
EX-99
prglxwbuyk83a2wf4u
12 Aug 13
Teva Pharmaceuticals and Perrigo Company Announce the U.s. Launch of Generic Temozolomide
12:00am
6-K
EX-99.1
zvwezw 8jq4jbz
8 Aug 13
Live Filing
12:00am
6-K
EX-99.1
n7tx gilv64fi5
1 Aug 13
Teva Reports Second Quarter 2013 Results
12:00am